These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8098225)

  • 41. Stress ulcer prevention and histamine-2-receptor antagonists: leaps of faith or back to the drawing board?
    Freedman MD
    Crit Care Med; 1999 Jan; 27(1):13-4. PubMed ID: 9934877
    [No Abstract]   [Full Text] [Related]  

  • 42. Only one proton-pump inhibitor for formulary.
    Hopefl A
    Am J Health Syst Pharm; 1996 Dec; 53(23):2882, 2884. PubMed ID: 8957352
    [No Abstract]   [Full Text] [Related]  

  • 43. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
    Pei Y; Wang B; Chen S
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 45. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage.
    Singh G; Triadafilopoulos G
    Int J Clin Pract; 2005 Oct; 59(10):1210-7. PubMed ID: 16178990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proton pump inhibitors.
    Grover JK; Vats V
    Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
    [No Abstract]   [Full Text] [Related]  

  • 47. Lansoprazole elevates the ratio of serum pepsinogen I v.s. pepsinogen II.
    Matsukawa Y; Nishinarita S; Kaneko M; Takei M; Murakami M; Horie T; Kawamura F; Arakawa Y; Kuwayama H; Kurosaka H
    Int J Clin Pharmacol Res; 1997; 17(4):127-32. PubMed ID: 9526173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Are proton pump inhibitors safe?].
    Creutzfeldt W
    Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
    [No Abstract]   [Full Text] [Related]  

  • 49. [Lansoprazole: an analysis of the clinical trials in the 3 years of 1997-1999].
    Dobrilla G; Capurso L
    Recenti Prog Med; 2000 Apr; 91(4):191-210. PubMed ID: 10804753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
    Yukawa K; Yukawa E
    Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Polaprezinc].
    Kuwayama H; Takahashi M; Suzuki K; Suga M; Takata H; Ohara T; Koizumi K; Kiriyama Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():717-20. PubMed ID: 11979877
    [No Abstract]   [Full Text] [Related]  

  • 53. The newest proton pump inhibitor.
    Claussen DW
    Gastroenterol Nurs; 1995; 18(6):235-6. PubMed ID: 8562590
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
    Bliesath H; Simon B; Hartmann M; Müller P; Schneider A; Lühmann R; Wurst W
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):439. PubMed ID: 1337063
    [No Abstract]   [Full Text] [Related]  

  • 55. Second proton-pump inhibitor marketed.
    Am J Health Syst Pharm; 1995 Aug; 52(15):1601. PubMed ID: 7583820
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of patients with Zollinger-Ellison syndrome.
    Mignon M; Pospai D; Forestier S; Vatier J; Vallot T
    Clin Ther; 1993; 15 Suppl B():22-31. PubMed ID: 8205592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.
    Miner P
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():20-9. PubMed ID: 15496215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.